Opening book details…
About this Medicine article
Patients With Acute Myeloid Leukemia and RAS Mutations Benefit Most From Postremission High-Dose Cytarabine: A Cancer and Leukemia Group B Study by Neubauer, A.; Maharry, K.; Mrozek, K.; Thiede, C.; Marcucci, G.; Paschka, P.; Mayer, R. J.; Larson, R. A.; Liu, E. T.; Bloomfield, C. D. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Neubauer, A.; Maharry, K.; Mrozek, K.; Thiede, C.; Marcucci, G.; Paschka, P.; Mayer, R. J.; Larson, R. A.; Liu, E. T.; Bloomfield, C. D.
- Publisher
- American Society of Clinical Oncology; American Society of Clinical Oncology (ASCO) (ISSN 0732-183X)
- Published
- 2008
- Language
- EN
- Field
- Medicine (Health Sciences)